These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7625921)

  • 1. Theoretical description of mass transport in medical membrane devices.
    Werynski A; Waniewski J
    Artif Organs; 1995 May; 19(5):420-7. PubMed ID: 7625921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of membrane processes for blood purification.
    Colton CK
    Blood Purif; 1987; 5(4):202-51. PubMed ID: 3322325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a reduced inner diameter of hollow fibers in hemodialyzers.
    Ronco C; Brendolan A; Lupi A; Metry G; Levin NW
    Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute transport in continuous arteriovenous hemodiafiltration: a new mathematical model applied to clinical data.
    Vincent HH; van Ittersum FJ; Akcahuseyin E; Vos MC; van Duyl WA; Schalekamp MA
    Blood Purif; 1990; 8(3):149-59. PubMed ID: 2244992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Required water quality for the use of high-performance membranes.
    Aoike I
    Contrib Nephrol; 2011; 173():53-57. PubMed ID: 21865776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future.
    Davenport A
    Minerva Urol Nefrol; 2010 Mar; 62(1):29-40. PubMed ID: 20424568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model of continuous arterio-venous hemodiafiltration (CAVHD).
    Akcahuseyin E; Vincent HH; van Ittersum FJ; van Duyl WA; Schalekamp MA
    Comput Methods Programs Biomed; 1990; 31(3-4):215-24. PubMed ID: 2364687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of tumor necrosis factor in hemodiafiltration].
    Tetta C; Segoloni G; Fidelio T; Licata C; Sancipriano GP; Iacono G; Ragni R; Vercellone A
    Minerva Urol Nefrol; 1991; 43(3):181-3. PubMed ID: 1817342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodiafiltration: choice or necessity in high-efficiency treatment?].
    Ghezzi PM; Gervasio R
    Minerva Urol Nefrol; 1990; 42(1):27-9. PubMed ID: 2202068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The simulation of continuous arteriovenous hemodialysis with a mathematical model.
    Pallone TL; Hyver S; Petersen J
    Kidney Int; 1989 Jan; 35(1):125-33. PubMed ID: 2709658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple use of plasmafilters.
    Lai KN; Lai FM; Lam CW
    J Clin Apher; 1987; 3(4):235-9. PubMed ID: 3680196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of backfiltration rates during hemodialysis with highly permeable membranes.
    Leypoldt JK; Schmidt B; Gurland HJ
    Blood Purif; 1991; 9(2):74-84. PubMed ID: 1760145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymethylmethacrylate: one biomaterial for a series of membrane.
    Takeyama T; Sakai Y
    Contrib Nephrol; 1999; 125():9-24. PubMed ID: 9895427
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluid mechanics and crossfiltration in hollow-fiber hemodialyzers.
    Ronco C
    Contrib Nephrol; 2007; 158():34-49. PubMed ID: 17684341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients.
    Klemm A; Sperschneider H; Winnefeld K; Günther K; Stein G
    Clin Nephrol; 1997 Feb; 47(2):133-4. PubMed ID: 9049466
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellulose triacetate: another membrane for continuous renal replacement therapy.
    Ronco C; Brendolan A; Everard P; Irone M; Ballestri M; Cappelli G; Inguaggiato P; Bellomo R
    J Nephrol; 1999; 12(4):241-7. PubMed ID: 10493567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polyamide membrane in hemodiafiltration.
    Gonella M; Calabrese G; Pratesi G; Mazzotta A; Vagelli G; Baldin C
    Contrib Nephrol; 1992; 96():99-105. PubMed ID: 1740054
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of membrane characteristics on the performance of Couette rotating plasma separation devices.
    Jaffrin M; Beaudoin G; Ding LH; Djennaoui N
    ASAIO Trans; 1989; 35(3):690-3. PubMed ID: 2597565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.